Loading...
Chemical structure of PF-4136309

GC25728

PF-4136309

Also known as N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrimidin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide

PF-4136309 (INCB8761, PF-04136309) is a potent, selective, and orally bioavailable CCR2 antagonist with an IC50 of 5·2 nM for human CCR2

ChemicalCAS857679-55-1MW568.59FormulaC29H31F3N6O3
CAS number
857679-55-1
Molecular weight
568.59
Formula
C29H31F3N6O3
Solubility
DMSO： 100 mg/mL (175·87 mM);Water： Insoluble;Ethanol： 100 mg/mL (175·87 mM)
InChIKey
ZNSVOHSYDRPBGI-CBQRAPNFSA-N
Catalogue number
GC25728
Brand
GLPBIO
Computed properties PubChem CID 11192346 · XLogP 2.2 · TPSA 120 Ų · H-bond donors 3
XLogP
2.2
TPSA
120 Ų
H-bond donors
3
H-bond acceptors
10
Rotatable bonds
7
Heavy atoms
41

SMILES C1CN(C[C@H]1NC2CCC(CC2)(C3=NC=C(C=C3)C4=NC=CC=N4)O)C(=O)CNC(=O)C5=CC(=CC=C5)C(F)(F)F

Computed descriptors from PubChem (CID 11192346), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.